Registry on Left Main Coronary Artery Bifurcation Percutaneous Intervention (WE REMAIN EBC)
Web-based Registry on Left Main From the Euro Bifurcation Club (WE REMAIN EBC)
Sponsor: Azienda Sanitaria Locale n. 2 - Lanciano Vasto Chieti
This observational or N/A phase trial investigates Coronary Arteriosclerosis and Left Main Coronary Artery Disease and is currently ongoing. Azienda Sanitaria Locale n. 2 - Lanciano Vasto Chieti leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Apr 2022 — Jul 2024 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Apr 2022 [monthly]
Not Yet Recruiting
-
Apr 2020 — Jan 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Sanitaria Locale n. 2 - Lanciano Vasto Chieti
- Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
- Chiba University
- Clinica Di Montevergine
- Clinica Mediterranea
- Clinical Centre of Serbia
- Clinical Hospital Centre Zagreb
- Federico II University
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- G. d'Annunzio University
- Hospital Clínico Universitario de Valladolid
- Hospital Pablo Tobón Uribe
- Hospital Universitario Reina Sofia de Cordoba
- Instituto Dante Pazzanese de Cardiologia
- Mount Sinai Hospital, New York
- Pauls Stradins Clinical University Hospital
- San Raffaele University Hospital, Italy
- University Hospital Monastir, Tunis
- University Medical Centre Maribor
- Université Paris-Sud
- VZW Cardiovascular Research Center Aalst
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.